High Net Worth Advisory Group LLC Autolus Therapeutics PLC Transaction History

High Net Worth Advisory Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.04 - $4.68 $4,080 - $9,360	-2,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.52 - $5.46 $3,520 - $5,460	1,000 Added 100.0%	2,000 $8,000
Q4 2021 Aug 10, 2022	SELL	$5.1 - $7.0 $5,100 - $7,000	-1,000 Reduced 50.0%	1,000 $5,000
Q4 2021 Apr 27, 2022	BUY	$5.1 - $7.0 $10,200 - $14,000	2,000 New	2,000 $9,000

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $208M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.